Attenuation of liver fibrosis by herbal compound 861 via upregulation of BMP-7/Smad signaling in the bile duct ligation model rat

Hou,Fei; Liu,Ruixia; Liu,Xiaoya; Cui,Lijian; Wen,Yan; Yan,Songbiao; Yin,Chenghong

doi:10.3892/mmr.2016.5071

Attenuation of liver fibrosis by herbal compound 861 via upregulation of BMP-7/Smad signaling in the bile duct ligation model rat

Authors:
- Fei Hou
- Ruixia Liu
- Xiaoya Liu
- Lijian Cui
- Yan Wen
- Songbiao Yan
- Chenghong Yin
View Affiliations

Affiliations: Department of Infection, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, P.R. China, Department of Internal Medicine, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100026, P.R. China
Published online on: March 30, 2016 https://doi.org/10.3892/mmr.2016.5071
Pages: 4335-4342

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Herbal compound 861 (Cpd 861) exerts an anti-fibrotic effect in patients with hepatic fibrosis; however, the anti-fibrotic mechanism has yet to be fully elucidated. The present study aimed to explore the mechanistic basis for the anti-fibrotic effect, with a focus on bone morphogenetic protein 7 (BMP-7)/Smad signaling in a bile duct ligation (BDL)-induced liver fibrosis rat model. Following the induction of hepatic fibrosis, rats induced by BDL were treated with 9 g/kg Cpd 861 daily or an equal volume of saline for 28 days. Serum samples were prepared for monitoring the levels of alanine transaminase, aspartate transaminase and total bilirubin, and direct bilirubin analyses and liver samples were used to investigate gene expression, protein localization and protein expression analysis using real‑time quantitative polymerase chain reaction, immunohistochemistry and western blotting. The results revealed the attenuation of liver fibrosis by Cpd 861 in the histological and biochemical experiments. BMP‑7 and phospho (p)‑Smad1/5/8 were localized predominantly in the cytoplasm of hepatocytes. In comparison with the saline‑treated BDL rats, Cpd 861 markedly upregulated the gene expression of BMP‑7 and Smad5, as well as the protein expression of BMP‑7 and Smad1/5. In addition, p-Smad1/5/8 protein expression was markedly increased by Cpd 861 in the BDL model. These results indicated that Cpd 861 alleviates hepatic fibrosis possibly via the upregulation and activation of BMP-7/Smad signaling in hepatic fibrotic rats.

View Figures

View References

1	Lim YS and Kim WR: The global impact of hepatic fibrosis and end-stage liver disease. Clin Liver Dis. 12:733–746. vii2008. View Article : Google Scholar : PubMed/NCBI
2	Moreira RK: Hepatic stellate cells and liver fibrosis. Arch Pathol Lab Med. 131:1728–1734. 2007.PubMed/NCBI
3	Brenner DA, Waterboer T, Choi SK, Lindquist JN, Stefanovic B, Burchardt E, Yamauchi M, Gillan A and Rippe RA: New aspects of hepatic fibrosis. J Hepatol. 32(Suppl 1): S32–S38. 2000. View Article : Google Scholar
4	Okuno M, Akita K, Moriwaki H, Kawada N, Ikeda K, Kaneda K, Suzuki Y and Kojima S: Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-β. Gastroenterology. 120:1784–1800. 2001. View Article : Google Scholar : PubMed/NCBI
5	Ling H, Roux E, Hempel D, Tao J, Smith M, Lonning S, Zuk A, Arbeeny C and Ledbetter S: Transforming growth factor β neutralization ameliorates pre-existing hepatic fibrosis and reduces cholangiocarcinoma in thioacetamide-treated rats. PLoS One. 8:e544992013. View Article : Google Scholar
6	Yata Y, Gotwals P, Koteliansky V and Rockey DC: Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-β soluble receptor: Implications for antifibrotic therapy. Hepatology. 35:1022–1030. 2002. View Article : Google Scholar : PubMed/NCBI
7	Reddi AH: Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol. 16:247–252. 1998. View Article : Google Scholar : PubMed/NCBI
8	Huo L, Liu K, Pei J, Yang Y, Ye Y, Liu Y, Sun J, Han H, Xu W and Gao Y: Fluoride promotes viability and differentiation of osteoblast-like Saos-2 cells via BMP/Smads signaling pathway. Biol Trace Elem Res. 155:142–149. 2013. View Article : Google Scholar : PubMed/NCBI
9	Kretzschmar M and Massagué J: SMADs: Mediators and regulators of TGF-β signaling. Curr Opin Genet Dev. 8:103–111. 1998. View Article : Google Scholar : PubMed/NCBI
10	Wang SL, Yang CQ, Qi XL, Yuan M, Chang YZ, Yang L and Gao HJ: Inhibitory effect of bone morphogenetic protein-7 on hepatic fibrosis in rats. Int J Clin Exp Pathol. 6:897–903. 2013.PubMed/NCBI
11	Chen BL, Peng J, Li QF, Yang M, Wang Y and Chen W: Exogenous bone morphogenetic protein-7 reduces hepatic fibrosis in Schistosoma japonicum-infected mice via transforming growth factor-β/Smad signaling. World J Gastroenterol. 19:1405–1415. 2013. View Article : Google Scholar : PubMed/NCBI
12	Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F and Kalluri R: BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med. 9:964–968. 2003. View Article : Google Scholar : PubMed/NCBI
13	Kinoshita K, Iimuro Y, Otogawa K, Saika S, Inagaki Y, Nakajima Y, Kawada N, Fujimoto J, Friedman SL and Ikeda K: Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats. Gut. 56:706–714. 2007. View Article : Google Scholar
14	Yin SS, Wang BE, Wang TL, Jia JD and Qian LX: The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: A randomized, double blind, placebo controlled clinical trial. Zhonghua Gan Zang Bing Za Zhi. 12:467–470. 2004.In Chinese. PubMed/NCBI
15	Wang L, Wang BE, Wang J, Xiao PG and Tan XH: Herbal compound 861 regulates mRNA expression of collagen synthesis- and degradation-related genes in human hepatic stellate cells. World J Gastroenterol. 14:1790–1794. 2008. View Article : Google Scholar : PubMed/NCBI
16	Wang L, Wang J, Wang BE, Xiao PG, Qiao YJ and Tan XH: Effects of herbal compound 861 on human hepatic stellate cell proliferation and activation. World J Gastroenterol. 10:2831–2835. 2004. View Article : Google Scholar : PubMed/NCBI
17	Aghaei I, Shabani M, Doustar N, Nazeri M and Dehpour A: Peroxisome proliferator-activated receptor-γ activation attenuates motor and cognition impairments induced by bile duct ligation in a rat model of hepatic cirrhosis. Pharmacol Biochem Behav. 120:133–139. 2014. View Article : Google Scholar : PubMed/NCBI
18	Javadi-Paydar M, Ghiassy B, Ebadian S, Rahimi N, Norouzi A and Dehpour AR: Nitric oxide mediates the beneficial effect of chronic naltrexone on cholestasis-induced memory impairment in male rats. Behav Pharmacol. 24:195–206. 2013. View Article : Google Scholar : PubMed/NCBI
19	Uchinami H, Seki E, Brenner DA and D'Armiento J: Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis. Hepatology. 44:420–429. 2006. View Article : Google Scholar : PubMed/NCBI
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
21	Shen H, Huang G, Hadi M, Choy P, Zhang M, Minuk GY, Chen Y and Gong Y: Transforming growth factor-beta1 downregulation of Smad1 gene expression in rat hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 285:G539–G546. 2003. View Article : Google Scholar : PubMed/NCBI
22	Yang T, Chen SL, Lu XJ, Shen CY, Liu Y and Chen YP: Bone morphogenetic protein 7 suppresses the progression of hepatic fibrosis and regulates the expression of gremlin and transforming growth factor β1. Mol Med Rep. 6:246–252. 2012.PubMed/NCBI
23	Ding HG, Tang SZ, Wang BE, Jia JD and Zhao CH: Effects of herbal compound 861 on hepatic stellate cell expressing endo-thelin-1 protein and mRNA. Chin J Hepatol. 11:3082003.In Chinese.
24	Yin C, Ma H, Wang A, Ma X, Jia J and Wang B: Effect of compound 861 on tissue inhibitor of metalloproteinase 1 gene expression of HSC-T6 cells. Chin J Hepatol. 10:197–199. 2002.In Chinese.
25	You H, Wang B and Wang T: Proliferation and apoptosis of hepatic stellate cells and effects of compound 861 on liver fibrosis. Chin J Hepatol. 8:78–80. 2000.In Chinese.
26	Cheifetz S, Li IW, McCulloch CA, Sampath K and Sodek J: Influence of osteogenic protein-1 (OP-1;BMP-7) and transforming growth factor-beta 1 on bone formation in vitro. Connect Tissue Res. 35:71–78. 1996. View Article : Google Scholar : PubMed/NCBI
27	Wang LP, Dong JZ, Xiong LJ, Shi KQ, Zou ZL, Zhang SN, Cao ST, Lin Z and Chen YP: BMP-7 attenuates liver fibrosis via regulation of epidermal growth factor receptor. Int J Clin Exp Pathol. 7:3537–3547. 2014.PubMed/NCBI
28	Heldin CH, Miyazono K and ten Dijke P: TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature. 390:465–471. 1997. View Article : Google Scholar : PubMed/NCBI
29	Wrana JL: Regulation of Smad activity. Cell. 100:189–192. 2000. View Article : Google Scholar : PubMed/NCBI
30	Wang S and Hirschberg R: Bone morphogenetic protein-7 signals opposing transforming growth factor beta in mesangial cells. J Biol Chem. 279:23200–23206. 2004. View Article : Google Scholar : PubMed/NCBI